Apyx Medical Statistics Share Statistics Apyx Medical has 37.79M
shares outstanding. The number of shares has increased by 9.09%
in one year.
Shares Outstanding 37.79M Shares Change (YoY) 9.09% Shares Change (QoQ) 0% Owned by Institutions (%) 44.43% Shares Floating 32.19M Failed to Deliver (FTD) Shares 9,803 FTD / Avg. Volume 4.49%
Short Selling Information The latest short interest is 299.21K, so 0.79% of the outstanding
shares have been sold short.
Short Interest 299.21K Short % of Shares Out 0.79% Short % of Float 0.84% Short Ratio (days to cover) 2.4
Valuation Ratios The PE ratio is -2.39 and the forward
PE ratio is -4.94.
Apyx Medical's PEG ratio is
-0.11.
PE Ratio -2.39 Forward PE -4.94 PS Ratio 1.17 Forward PS 1.7 PB Ratio 3.95 P/FCF Ratio -2.99 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Apyx Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.26,
with a Debt / Equity ratio of 2.73.
Current Ratio 5.26 Quick Ratio 4.56 Debt / Equity 2.73 Debt / EBITDA -2.31 Debt / FCF -2.07 Interest Coverage -3.19
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $218.65K Profits Per Employee $-106.65K Employee Count 220 Asset Turnover 0.74 Inventory Turnover 2.48
Taxes Income Tax 252K Effective Tax Rate -1.08%
Stock Price Statistics The stock price has increased by 114.15% in the
last 52 weeks. The beta is 1.39, so Apyx Medical's
price volatility has been higher than the market average.
Beta 1.39 52-Week Price Change 114.15% 50-Day Moving Average 2.01 200-Day Moving Average 1.51 Relative Strength Index (RSI) 53.82 Average Volume (20 Days) 218,467
Income Statement In the last 12 months, Apyx Medical had revenue of 48.1M
and earned -23.46M
in profits. Earnings per share was -0.66.
Revenue 48.1M Gross Profit 29.36M Operating Income -18.84M Net Income -23.46M EBITDA -16.8M EBIT -17.4M Earnings Per Share (EPS) -0.66
Full Income Statement Balance Sheet The company has 31.74M in cash and 38.76M in
debt, giving a net cash position of -7.02M.
Cash & Cash Equivalents 31.74M Total Debt 38.76M Net Cash -7.02M Retained Earnings -77.91M Total Assets 60.16M Working Capital 42.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -18.05M
and capital expenditures -722K, giving a free cash flow of -18.77M.
Operating Cash Flow -18.05M Capital Expenditures -722K Free Cash Flow -18.77M FCF Per Share -0.53
Full Cash Flow Statement Margins Gross margin is 61.04%, with operating and profit margins of -39.18% and -48.78%.
Gross Margin 61.04% Operating Margin -39.18% Pretax Margin -48.45% Profit Margin -48.78% EBITDA Margin -34.93% EBIT Margin -39.18% FCF Margin -39.02%
